May 24 2024 This Week in Cardiology

Clues in SCAF, a DOAC antidote trial, another negative lytic trial in stroke, JAMA changes to observational studies, and BP in stroke care are the topics John Mandrola, MD, covers in this week’s podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
www.medscape.com/twic
I. ARTESIA Substudy
Sadly, ARTESIA Doesn't Answer a Common Question in Cardiology
www.medscape.com/viewarticle/...

• ARTESIA Substudy
• NOAH www.nejm.org/doi/full/10.1056...
• ARTESIA www.nejm.org/doi/10.1056/NEJM...
II. DOAC Reversal

• ANNEXA-1 Trial www.nejm.org/doi/full/10.1056...
III. Lytic Therapy in Acute Stroke
Thrombolysis Offers No Benefit for Mild Stroke
www.medscape.com/viewarticle/...

• TEMPO-2 Trial doi.org/10.1016/S0140-6736(24...
• The Case Against Thrombolytic Therapy in Stroke
IV. Observational Research

• JAMA Special Communication jamanetwork.com/journals/jama...
• JAMA editors note jamanetwork.com/journals/jama...
V. Aggressive BP Control in Stroke
Guidelines on Rapid BP Reduction in Acute Ischemic Stroke Challenged
www.medscape.com/viewarticle/...

• TRUTH Trial doi.org/10.1016/S1474-4422(24...
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. www.medscape.com/author/bob-h...
Questions or feedback, please contact [e-mail]